Navigation Links
Islet Sciences, Inc. Selects NeoStem's Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
Date:1/12/2012

em's extensive research capabilities that positions the company as a leader in cell therapy development. Amorcyte, Inc., also a NeoStem company, is developing a cell therapy for the treatment of cardiovascular disease. Amorcyte's lead compound, AMR-001, represents NeoStem's most clinically advanced therapeutic and  has commenced enrollment in a Phase 2 trial for the preservation of heart function after a heart attack.  Amorcyte expects to begin a Phase 1 clinical trial in 2012 for AMR-001 for the treatment of patients with congestive heart failure. Athelos Corporation, also a NeoStem company, is developing a T-cell therapy for a range of autoimmune conditions with its partner Becton-Dickinson.  NeoStem's pre-clinical assets include its VSEL™ Technology platform for regenerative medicine, which NeoStem believes to be an endogenous, pluripotent, non-embryonic stem cell that has the potential to change the paradigm of cell therapy as we know it today.

For more information on NeoStem, please visit www.neostem.com.

About Islet Sciences, Inc.Islet Sciences is a development-stage biotechnology company with patented technologies focused on transplantation therapy for people with insulin-dependent diabetes. Islet's transplantation technology includes methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. Islet's mission includes the introduction of commercial products with applications to cell-based replacement therapy in the healthcare marketplace.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements for NeoStem, PCT and Islet Sciences reflect thei
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes
2. Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research
3. Beta-Pro Donates Human Islet Cells to Diabetes Researcher
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
5. Milestone Biosciences, LLC Further Strengthens Executive Management Team
6. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
7. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
8. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
9. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
10. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
11. Pressure BioSciences, Inc. Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... (PRWEB) December 13, 2014 According to ... million people between now and 2030." If a population ... the seventh most populous state in the country. , ... gathering at the Future of North Carolina Forum on ... Do we have the necessary infrastructure in place? Enough ...
(Date:12/13/2014)... Texas , Dec. 12, 2014  Vermillion, Inc. ... announced today the appointments of Veronica G. H. ... to the Company,s Board of Directors, bringing the total ... independent. Jim LaFrance , Chairman, ... am tremendously pleased to announce the appointments of Veronica ...
(Date:12/13/2014)... ROCHESTER, N.Y. , Dec. 12, 2014 ... engaged in the discovery and development of ... neurodegenerative diseases, today announced publication of a ... microglia, and inhibits remyelination in neurodegenerative disease" ... journal Neurobiology of Disease*.  The publication highlights ...
(Date:12/12/2014)... December 11, 2014 InSphero AG, the ... efficacy testing, announced today that data presented recently by ... microtissues as a more predictive model system for assessment ... the 2nd Annual Functional Analysis and Screening Technologies ... the response of InSphero’s 3D InSight™ Human Liver ...
Breaking Biology Technology:North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 3
... PITTSBURGH, Oct. 7 Today the National Collegiate ... of BMEStart, an award recognizing undergraduate excellence in ... other biomedical competition (BMEidea) because of its focus ... much experience with product development. , The ...
... (Nasdaq: SGMO ) today announced the pricing of a ... The offering is expected to close on or about October ... In addition, Sangamo has granted the underwriter a 30-day ... common stock to cover over-allotments, if any. , ...
... , DUBLIN, October 7 , ... Only - , - Direct Comparison ... Efficacy , Shire plc (LSE: SHP, ... the publication in Clinical,Nephrology of findings from a head-to-head clinical ...
Cached Biology Technology:NCIIA Announces New Undergraduate Competition 2Sangamo Announces Pricing of Public Offering of Common Stock 2Sangamo Announces Pricing of Public Offering of Common Stock 3Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 2Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 3Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 4Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 5Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 6
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:12/3/2014)... 2, 2014 As part of our commitment ... is pleased to announce the release of a new ... collect the workforce data that they need. ... left by existing readers. Many such devices have serious ... modern technology. Older models force users to navigate numerous ...
(Date:11/21/2014)... Strict laws against distracted driving and the ... American and European automotive sector towards gesture recognition technologies. ... that are intuitive and able to retrieve information with ... New analysis from Frost & Sullivan,s Strategic ... Europe and North America ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... stomach may be nearly as unique as your fingerprint, ... Medicine who have embarked on the early stages of ... detect all known types of microbes and borrowing statistical ... MD, a postdoctoral scholar in infectious diseases and geographic ...
... question of whether amino acids in sandwich-like proteins are ... the protein-folding process is best answered by "all of ... Houston. , This discovery, reported in today's issue of ... benefit future research on treatments for diseases related to ...
... Ebola virus reproduction in laboratory-grown cells is severely ... further study as possible treatments for Ebola virus ... by the National Institute of Allergy and Infectious ... of Health (NIH). , The researchers, whose paper ...
Cached Biology News:Stanford gut check shows diversity of intestinal ecosystem 2Stanford gut check shows diversity of intestinal ecosystem 3Conserved amino acids play both structural and mechanistic roles in sandwich-like protein 2Scientists discover how Ebola virus infects cells 2
... The ProteoExtract™ Protein Precipitation Kit is ... of proteins from aqueous samples. Proteomics ... the presence of non-protein impurities such ... the protein sample that interfere with ...
... luminometer provides the sensitivity and versatility you ... digital photon counting with selected photomultipliers ensure ... demands. Equipped with up to 2 reagent ... reporter gene assays as well as other ...
... high-speed analytical techniques, the AutoTrace SPE is a powerful, high-throughput workstation dedicated specifically ... loading and elution steps for large volumes aqueous solution extractions (up to 2000ml's). ... ... ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Biology Products: